Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic

Thomas Zeller*, Elias Noory, Ulrich Beschorner, Tanja Böhme, Michel M.P.J. Reijnen

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)109-111
Number of pages3
JournalVasa - European Journal of Vascular Medicine
Issue number2
Publication statusPublished - Mar 2019

Cite this